High-efficiency liposomal encapsulation of a tyrosine kinase inhibitor leads to improved in vivo toxicity and tumor response profile
Milan Makale(University of California San Diego), Santosh Kesari(Cancer Institute (WIA))
Cited by 33
Related Papers
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
|Journal of Translational Medicine|2018|540
Diffusion-Weighted Imaging in Cancer: Physical Foundations and Applications of Restriction Spectrum Imaging
|Cancer Research|2014|264
ANG1005, a Brain-Penetrating Peptide–Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases
|Clinical Cancer Research|2020|242
In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells
|British Journal of Cancer|2014|192